A cocktail of antibodies against Ebola yielded promising but not conclusive results in a randomized trial conducted in the waning months of the West African epidemic, researchers reported.
A cocktail of antibodies against Ebola yielded promising but not conclusive results in a randomized trial conducted in the waning months of the West African epidemic, researchers reported.